• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钾稳态与钾代谢紊乱:肾脏、肾外及肠道感受器在钾处理中的各自作用。

Potassium homeostasis and dyskalemias: the respective roles of renal, extrarenal, and gut sensors in potassium handling.

作者信息

Epstein Murray, Lifschitz Meyer D

机构信息

Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, FL, USA.

Adult Nephrology Unit, Shaare Zedek Medical Center, Jerusalem, Israel.

出版信息

Kidney Int Suppl (2011). 2016 Apr;6(1):7-15. doi: 10.1016/j.kisu.2016.01.006. Epub 2016 Mar 14.

DOI:10.1016/j.kisu.2016.01.006
PMID:30675414
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6340905/
Abstract

Integrated mechanisms controlling the maintenance of potassium homeostasis are well established and are defined by the classic "feedback control" of potassium balance. Recently, increasing investigative attention has focused on novel physiological paradigms that increase the complexity and precision of homeostasis. This review briefly considers the classic and well-established feedback control of potassium and then considers subsequent investigations that inform on an intriguing and not widely recognized complementary paradigm: the "feed-forward control of potassium balance." Feed-forward control refers to a pathway in a homeostatic system that responds to a signal in the environment in a predetermined manner, without responding to how the system subsequently reacts (i.e., without responding to feedback). Studies in several animal species, and recently in humans, have confirmed the presence of a feed-forward control mechanism that is capable of mediating potassium excretion independent of changes in serum potassium concentration and aldosterone. Knowledge imparted by this update of potassium homeostasis hopefully will facilitate the clinical management of hyperkalemia in patients with chronic and recurrent hyperkalemia. Awareness of this updated integrative control mechanism for potassium homeostasis is more relevant today when the medical community is increasingly focused on leveraging and expanding established renin-angiotensin-aldosterone system inhibitor treatment regimens and on successfully coping with the challenges of managing hyperkalemia provoked by renin-angiotensin-aldosterone system inhibitors. These new insights are relevant to the future design of clinical trials delineating renal potassium handling.

摘要

控制钾稳态维持的综合机制已得到充分确立,并由经典的钾平衡“反馈控制”所定义。最近,越来越多的研究关注于新型生理模式,这些模式增加了稳态的复杂性和精确性。本综述简要回顾了经典且已确立的钾反馈控制,然后考虑了后续的研究,这些研究揭示了一种有趣但未被广泛认可的互补模式:“钾平衡的前馈控制”。前馈控制是指稳态系统中的一条通路,它以预定的方式对环境中的信号做出反应,而不响应系统随后的反应(即不响应反馈)。对几种动物物种以及最近对人类的研究已经证实,存在一种前馈控制机制,该机制能够独立于血清钾浓度和醛固酮的变化来调节钾排泄。钾稳态的这一更新所带来的知识有望促进慢性和复发性高钾血症患者高钾血症的临床管理。当医学界越来越关注利用和扩展已确立的肾素 - 血管紧张素 - 醛固酮系统抑制剂治疗方案,以及成功应对肾素 - 血管紧张素 - 醛固酮系统抑制剂引发的高钾血症管理挑战时,了解这种更新的钾稳态综合控制机制在当今更为重要。这些新见解与未来描述肾脏钾处理的临床试验设计相关。

相似文献

1
Potassium homeostasis and dyskalemias: the respective roles of renal, extrarenal, and gut sensors in potassium handling.钾稳态与钾代谢紊乱:肾脏、肾外及肠道感受器在钾处理中的各自作用。
Kidney Int Suppl (2011). 2016 Apr;6(1):7-15. doi: 10.1016/j.kisu.2016.01.006. Epub 2016 Mar 14.
2
The Unappreciated Role of Extrarenal and Gut Sensors in Modulating Renal Potassium Handling: Implications for Diagnosis of Dyskalemias and Interpreting Clinical Trials.肾外和肠道传感器在调节肾脏钾处理中的未被重视的作用:对钾代谢异常诊断及临床试验解读的意义
Kidney Int Rep. 2016 Apr 8;1(1):43-56. doi: 10.1016/j.ekir.2016.03.001. eCollection 2016 May.
3
Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.钾离子稳态和肾素-血管紧张素-醛固酮系统抑制剂。
Clin J Am Soc Nephrol. 2010 Mar;5(3):531-48. doi: 10.2215/CJN.07821109. Epub 2010 Feb 11.
4
Regulation of Potassium Homeostasis in CKD.慢性肾脏病中钾稳态的调节
Adv Chronic Kidney Dis. 2017 Sep;24(5):305-314. doi: 10.1053/j.ackd.2017.06.002.
5
Mechanisms of impaired potassium handling with dual renin-angiotensin-aldosterone blockade in chronic kidney disease.慢性肾脏病中双重肾素-血管紧张素-醛固酮阻断导致钾处理受损的机制
Hypertension. 2009 May;53(5):754-60. doi: 10.1161/HYPERTENSIONAHA.108.125252. Epub 2009 Mar 23.
6
Potassium-Binding Agents to Facilitate Renin-Angiotensin-Aldosterone System Inhibitor Therapy.促进肾素-血管紧张素-醛固酮系统抑制剂治疗的钾结合剂
Ann Pharmacother. 2016 Jun;50(6):502-10. doi: 10.1177/1060028016640794. Epub 2016 Mar 23.
7
Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study.高钾血症相关的肾素-血管紧张素-醛固酮系统抑制剂停药与 CKD 临床结局的相关性:一项基于人群的队列研究。
Am J Kidney Dis. 2022 Aug;80(2):164-173.e1. doi: 10.1053/j.ajkd.2022.01.002. Epub 2022 Jan 25.
8
Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.使用培多美索治疗可降低慢性肾脏病和肾素-血管紧张素系统抑制剂治疗高钾血症患者的醛固酮水平。
Kidney Int. 2016 Sep;90(3):696-704. doi: 10.1016/j.kint.2016.04.019. Epub 2016 Jun 24.
9
New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors.治疗肾素-血管紧张素-醛固酮系统抑制剂治疗患者高钾血症的新治疗方法。
Cardiovasc Drugs Ther. 2018 Feb;32(1):99-119. doi: 10.1007/s10557-017-6767-5.
10
Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study.尿血管紧张素原水平与多囊肾病患者的钾稳态和临床结局相关:一项前瞻性队列研究。
BMC Nephrol. 2019 Mar 25;20(1):104. doi: 10.1186/s12882-019-1292-3.

引用本文的文献

1
Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options.慢性肾脏病患者慢性高钾血症的管理:一个有新选择的老问题。
Front Med (Lausanne). 2021 Jun 4;8:653634. doi: 10.3389/fmed.2021.653634. eCollection 2021.
2
Current and future treatment options for managing hyperkalemia.高钾血症管理的当前及未来治疗选择
Kidney Int Suppl (2011). 2016 Apr;6(1):29-34. doi: 10.1016/j.kisu.2016.01.005. Epub 2016 Mar 14.

本文引用的文献

1
Current and future treatment options for managing hyperkalemia.高钾血症管理的当前及未来治疗选择
Kidney Int Suppl (2011). 2016 Apr;6(1):29-34. doi: 10.1016/j.kisu.2016.01.005. Epub 2016 Mar 14.
2
Hyperkalemia constitutes a constraint for implementing renin-angiotensin-aldosterone inhibition: the widening gap between mandated treatment guidelines and the real-world clinical arena.高钾血症是实施肾素-血管紧张素-醛固酮抑制治疗的一个限制因素:这一限制因素导致既定治疗指南与现实临床领域之间的差距不断扩大。
Kidney Int Suppl (2011). 2016 Apr;6(1):20-28. doi: 10.1016/j.kisu.2016.01.004. Epub 2016 Mar 14.
3
Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors.肾素-血管紧张素-醛固酮系统抑制剂临床指南与使用情况之间治疗差距的评估
Am J Manag Care. 2015 Sep;21(11 Suppl):S212-20.
4
Reduction of cardiovascular risk in chronic kidney disease by mineralocorticoid receptor antagonism.通过盐皮质激素受体拮抗作用降低慢性肾脏病的心血管风险。
Lancet Diabetes Endocrinol. 2015 Dec;3(12):993-1003. doi: 10.1016/S2213-8587(15)00289-2. Epub 2015 Sep 28.
5
Evidence for a gastrointestinal-renal kaliuretic signaling axis in humans.人类胃肠道-肾脏排钾信号轴的证据。
Kidney Int. 2015 Dec;88(6):1383-1391. doi: 10.1038/ki.2015.243. Epub 2015 Aug 26.
6
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.聚磺苯乙烯钠散对高钾血症合并糖尿病肾病患者血钾水平的影响:AMEHTYST-DN 随机临床试验。
JAMA. 2015 Jul 14;314(2):151-61. doi: 10.1001/jama.2015.7446.
7
An Integrated View of Potassium Homeostasis.钾稳态的综合观点。
N Engl J Med. 2015 Jul 2;373(1):60-72. doi: 10.1056/NEJMra1313341.
8
A mechanism for mineralocortcoid participation in renal disease and heart failure.一种盐皮质激素参与肾脏疾病和心力衰竭的机制。
J Am Soc Hypertens. 2015 Aug;9(8):586-91. doi: 10.1016/j.jash.2015.05.002. Epub 2015 May 15.
9
Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study.血管紧张素转换酶抑制剂或血管紧张素受体拮抗剂与心力衰竭伴严重肾功能不全患者死亡率的相关性:一项前瞻性倾向评分匹配队列研究。
Eur Heart J. 2015 Sep 7;36(34):2318-26. doi: 10.1093/eurheartj/ehv268. Epub 2015 Jun 11.
10
Standards of medical care in diabetes-2015 abridged for primary care providers.《2015年糖尿病医疗护理标准》(初级医疗服务提供者简版)
Clin Diabetes. 2015 Apr;33(2):97-111. doi: 10.2337/diaclin.33.2.97.